"10.1371_journal.pone.0074891","plos one","2013-09-30T00:00:00Z","Fei Shen; Pamela R Tsuruda; Jacqueline A M Smith; Glenmar P Obedencio; William J Martin","Departments of Pharmacology, Theravance Inc., South San Francisco, California, United States of America; Departments of Molecular and Cell Biology, Theravance Inc., South San Francisco, California, United States of America","Conceived and designed the experiments: FS PRT JAMS GPO WJM. Performed the experiments: FS PRT GPO. Analyzed the data: FS PRT JAMS GPO WJM. Contributed reagents/materials/analysis tools: FS PRT JAMS GPO WJM. Wrote the paper: FS PRT JAMS GPO WJM.","The authors are current employees of Theravance, Inc., a commercial company which has an interest in the development of novel monoamine reuptake inhibitors. Pending Patents: Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. All materials used in this publication are commercially available.","2013","09","Fei Shen","FS",5,TRUE,5,3,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
